Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

J Gutierrez, TN Turan, BL Hoh… - The Lancet Neurology, 2022 - thelancet.com
Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke
worldwide and confers one of the greatest risks of recurrent stroke compared with other …

Neuroprotective effect of SGLT2 inhibitors

A Pawlos, M Broncel, E Woźniak, P Gorzelak-Pabiś - Molecules, 2021 - mdpi.com
Patients with diabetes are at higher risk of cardiovascular diseases and cognitive
impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin …

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of …

BV Zlokovic, RF Gottesman, KE Bernstein… - Alzheimer's & …, 2020 - Wiley Online Library
Vascular contributions to cognitive impairment and dementia (VCID) are characterized by
the aging neurovascular unit being confronted with and failing to cope with biological insults …

[HTML][HTML] Emerging concepts in vascular dementia: a review

SC Bir, MW Khan, V Javalkar, EG Toledo… - Journal of Stroke and …, 2021 - Elsevier
Abstract Objective Vascular dementia (VaD) is the second most common cause of dementia
and a major health concern worldwide. A comprehensive review on VaD is warranted for …

Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?

K Govindpani, LG McNamara, NR Smith… - Journal of clinical …, 2019 - mdpi.com
Alzheimer's disease (AD) is the most prevalent form of dementia. Despite decades of
research following several theoretical and clinical lines, all existing treatments for the …

European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease

M Psychogios, A Brehm… - European Stroke …, 2022 - journals.sagepub.com
The aim of the present European Stroke Organisation guideline is to provide clinically useful
evidence-based recommendations on the management of patients with intracranial …

Cerebrovascular alterations in Alzheimer disease: incidental or pathogenic?

C Iadecola, RF Gottesman - Circulation research, 2018 - Am Heart Assoc
Experimental studies suggest that Aβ can reduce cerebral blood flow, induce neurovascular
dysfunction, and increase the susceptibility of the brain to ischemia. 2 Indeed, patients with a …

Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy

MT Duong, IM Nasrallah, DA Wolk… - Frontiers in Aging …, 2021 - frontiersin.org
Vascular contributions to cognitive impairment and dementia (VCID) are a common cause of
cognitive decline, yet limited therapies exist. This cerebrovascular disease results in …

Intracranial atherosclerotic disease

Y Wang, R Meng, G Liu, C Cao, F Chen, K Jin, X Ji… - Neurobiology of …, 2019 - Elsevier
Intracranial atherosclerosis (ICAS) is a progressive pathological process that causes
progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence …

Vascular cognitive impairment

J Graff-Radford - Continuum: Lifelong Learning in Neurology, 2019 - journals.lww.com
Vascular Cognitive Impairment : CONTINUUM: Lifelong Learning in Neurology Account
Register Activate Subscription Help Subscribe American Academy of Neurology Login Journal …